Top 5 drugs advertising in professional health journals through June 2015
Print advertising dollars in professional health journals reached almost $300 million through June 2015, a 1.6% decrease year-over-year, according to Kantar Media.
Of the top ten products being advertised in professional health journals through June 2015, only three were on the list at this time in 2014.
Top 5 Print Ad Drugs (Dollars): YTD May 2015
- Invokana – $5.66 MM (-50.5%)
- Trulicity – $5.49 MM (N/A)
- Xarelto Tablets – $4.66 MM (4.6%)
- Vyvanse – $4.04 MM (245.1%)
- Harvoni Tablets – $3.61 MM (N/A)
The percentage changes compare January 2014–June 2014 to January–June 2015. For more information on these ad insights or other data, let us know.
Kantar Media sets the standard for accurate, comprehensive competitive advertising intelligence in professional healthcare. Check back next month for updated data on the top products, classes, companies and category movers year-to-date.